Literature DB >> 11579006

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.

C Barrowclough1, G Haddock, N Tarrier, S W Lewis, J Moring, R O'Brien, N Schofield, J McGovern.   

Abstract

OBJECTIVE: Comorbidity of substance abuse disorders with schizophrenia is associated with a greater risk for serious illness complications and poorer outcome. Methodologically sound studies investigating treatment approaches for patients with these disorders are rare, although recommendations for integrated and comprehensive treatment programs abound. This study investigates the relative benefit of adding an integrated psychological and psychosocial treatment program to routine psychiatric care for patients with schizophrenia and substance use disorders.
METHOD: The authors conducted a randomized, single-blind controlled comparison of routine care with a program of routine care integrated with motivational interviewing, cognitive behavior therapy, and family or caregiver intervention.
RESULTS: The integrated treatment program resulted in significantly greater improvement in patients' general functioning than routine care alone at the end of treatment and 12 months after the beginning of the study. Other benefits of the program included a reduction in positive symptoms and in symptom exacerbations and an increase in the percent of days of abstinence from drugs or alcohol over the 12-month period from baseline to follow-up.
CONCLUSIONS: These findings demonstrate the effectiveness of a program of routine care integrated with motivational interviewing, cognitive behavior therapy, and family intervention over routine psychiatric care alone for patients with comorbid schizophrenia and alcohol or drug abuse or dependence.

Entities:  

Mesh:

Year:  2001        PMID: 11579006     DOI: 10.1176/appi.ajp.158.10.1706

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  68 in total

1.  Outcome assessment of the Medicaid managed care program in Harris County (Houston).

Authors:  Patricia M Averill; Pedro Ruiz; David R Small; Robert W Guynn; Oleg Tcheremissine
Journal:  Psychiatr Q       Date:  2003

2.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 3.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

4.  Unmet need for community-based mental health and substance use treatment among rural adolescents.

Authors:  Rachel L Anderson; Josephine Gittler
Journal:  Community Ment Health J       Date:  2005-02

5.  Family interventions for mental disorders: efficacy and effectiveness.

Authors:  Ian R H Falloon
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

6.  Issues in the dissemination of family intervention for psychosis.

Authors:  Christine Barrowclough
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

Review 7.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

8.  A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders.

Authors:  David A Graeber; Theresa B Moyers; Gayle Griffith; Eliseo Guajardo; Scott Tonigan
Journal:  Community Ment Health J       Date:  2003-06

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

10.  Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

Authors:  David Kimhy; Kelly Durbin; Cheryl M Corcoran
Journal:  Prim psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.